Polymorphism of Plasmodium falciparum Na+/H+ exchanger is indicative of a low in vitro quinine susceptibility in isolates from Viet Nam

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Sinou, Véronique ^a   Quang, Le Hong ^b   Pelleau, Stéphane ^a   Huong, Vu Nhu ^b   Huong, Nguyen Thu ^c   Tai, Le Minh ^b   Bertaux, Lionel ^a   Desbordes, Marc ^a   Latour, Christine ^a   Long, Lai Quang ^c   Thanh, Nguyen Xuan ^d   Parzy, Daniel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Military Center of Preventive Medicine   (Viet Nam)

^c Military Center of Drug Analysis and Research   (Viet Nam)

^d NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; QUININE; SODIUM PROTON EXCHANGE PROTEIN; ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CAMBODIA; DNA POLYMORPHISM; GENE; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; IC 50; IMMUNODETECTION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; VIET NAM; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; PARASITOLOGY;

ANTIMALARIALS; DRUG RESISTANCE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; QUININE; SODIUM-HYDROGEN ANTIPORTER; VIETNAM;

EID: 79958294622     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-164     Document Type: Article

References (40)

1. WHO: Global and antimalarial drug efficacy and drug resistance 2000-2010, 2010 http://malaria.who.int/malaria
2. Treatment of quinine resistant falciparum malairia in Thai children. T Chongsuphajaisiddhi A Sabchareon P Attanah, Southeast Asian J Trop Med Public Health 1983 14 357 362 6362017 (Pubitemid 14208945)
3. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. S Pukrittayakamee W Supanaranond S Looareesuwan S Vanijanonta NJ White, Trans R Soc Trop Med Hyg 1994 88 324 327 10.1016/0035-9203(94)90102-3 7974679 (Pubitemid 24206458)
4. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. S Pukrittayakamee A Chantra S Vanijanonta R Clemens S Looareesuwan NJ White, Antimicrob Agents Chemother 2000 44 2395 2398 10.1128/AAC.44.9.2395-2398.2000 10952585 (Pubitemid 30650885)
5. Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. PJ De Vries NN Bich HV Thien LN Hung TK Anh PA Kager SH Heisterkamp, Antimicrob Agents Chemother 2000 44 1302 1308 10.1128/AAC.44.5.1302-1308.2000 10770766 (Pubitemid 30228309)
6. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. MT Duraisingh P Jones I Sambou L von Seidlein M Pinder DC Warhurst, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315 (Pubitemid 30236312)
7. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. MB Reed KJ Saliba SR Caruana K Kirk AF Cowman, Nature 2000 403 906 909 10.1038/35002615 10706290 (Pubitemid 30130994)
8. Dissecting the loci of low-level quinine resistance in malaria parasites. MT Ferdig RA Cooper J Mu B Deng DA Joy XZ Su TE Wellems, Mol Microbiol 2004 52 985 997 10.1111/j.1365-2958.2004.04035.x 15130119 (Pubitemid 38916169)
9. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. RN Price AC Uhlemann A Brockman R McGready E Ashley L Phaipun R Patel K Laing S Looareesuwan NJ White F Nosten S Krishna, Lancet 2004 364 438 47 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
10. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine and artemisinin. AB Sidhu AC Uhlemann SG Valderramos JC Valderramos S Krishna DA Fidock, J Infect Dis 2006 194 528 535 10.1086/507115 16845638 (Pubitemid 44162666)
11. + exchanger activity and quinine resistance. TN Bennett J Patel MT Ferdig PD Roepe, Mol Biochem Parasitol 2007 153 8 58
12. +) exchanger. NJ Spillman RJ Allen K Kirk, Mol Biochem Parasitol 2008 162 96 99 10.1016/j.molbiopara.2008.07.001 18675853
13. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. DK Raj J Mu H Jiang J Kabat S Singh M Sullivan MP Fay TF McCutchan XZ Su, J Biol Chem 2009 284 7687 7696 10.1074/jbc.M806944200 19117944
14. Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a train-specific contribution of the sodium-proton exchanger PfNHE. LJ Nkrumah PM Riegelhaupt P Moura DJ Johnson J Patel K Hayton MT Ferdig TE Wellems MH Akabas DA Fidock, Mol Biochem Parasitol 2009 165 122 131 10.1016/j.molbiopara.2009.01.011 19428659
15. + exchanger 1 transporter is involved in reduced susceptibility to quinine. M Henry S Briolant A Zettor S Pelleau M Baragatti E Baret J Mosnier R Amalvict T Fusai C Rogier B Pradines, Antimicrob Agents Chemother 2010 53 1926 1930
16. + exchanger. H Meng R Zhang H Yang Q Fan X Su J Miao L Cui Z Yang, Antimicrob Agents Chemother 2010 10 4306 4313
17. In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium falciparum isolates from Kenya. J Okombo SM Kiara J Rono L Mwai L Pole E Ohuma S Borrmann LI Ochola A Nzila, Antimicrob Agents Chemother 2010 54 3302 3307 10.1128/AAC.00325-10 20516285
18. Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. FN Baliraine SL Nsobya J Achan JK Tibenderana AO Talisuna B Greenhouse PJ Rosenthal, Antimicrob Agents Chemother 2010
19. Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. V Andriantsoanirina D Ménard S Rabearimanana V Hubert C Bouchier M Tichit J Le Bras R Durand, Am J Trop Med Hyg 2010 82 782 787 10.4269/ajtmh.2010.09-0327 20439955
20. + exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo. S Briolant S Pelleau H Bogreau P Hovette A Zettor J Castello E Baret R Amalvict C Rogier B Pradines, Malar J 2011 10 37 10.1186/1475-2875-10-37 21314947
21. Update on genetic markers of quinine resistance in Plasmodium falciparum. J Okombo E Ohuma S Picot A Nzila, Mol Biochem Parasiol 2011
22. Pasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction. S Viriyakosol N Siripoon XP Zhu W Jarra A Seugorn KN Brown G Snounou, Exp Parasitol 1994 79 517 525 10.1006/expr.1994.1112 8001662
23. Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture. S Nsobya M Kiggundu M Joloba G Dorsey PJ Rosenthal, J Infect Dis 2008 198 1554 1557 10.1086/592506 18808336
24. Analysis of PFCRT, PFMDR1 and DHPS mutations and drug sensitivites in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisisnin. T Ngo M Duraisingh M Reed D Hipgrave B Biggs A Cowman, Am J Trop Med Hyg 2003 68 350 356 12685644 (Pubitemid 38240527)
25. Quantitative assessment of antimalarial activity in vitro by a semi-automatic microdilution technique. RE Desjardins CJ Canfield JD Haynes JD Chulay, Antimicrob Agents Chemother 1979 16 710 718 394674 (Pubitemid 10082023)
26. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. H Noedl B Attlmayr WH Wernsdorfer H Kollaritsch RS Miller, Am J Trop Med Hyg 2004 71 711 714 15642959 (Pubitemid 40075618)
27. Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. H Bogreau F Renaud H Bouchiba P Durand S-B Assi M-C Henry E Garnotel B Pradines T Fusai B Wade E Adehossi P Parola MA Kamil O Puijalon C Rogier, Am J Trop Med Hyg 2006 74 953 959 16760503 (Pubitemid 351627399)
28. A molecular marker for chloroquine-resistant falciparum malaria. A Djimdé OK Doumbo JF Cortese JF Kayentao S Doumbo Y Diourte A Dicko XZ Su T Nomura DA Fidock TE Wellems CV Plowe D Coulibaly, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
29. LK Basco, Field application of in vitro assay for the sensitivity of human malaria parasites to antimalarial drugs World Health Organization 2007
30. Ministry of Health, Guidelines for Malaria Diagnosis and Treatment in Vietnam 2006
31. Use and quality of antimalarial drugs in the private sector in Viet Nam. LD Cong PT Yen T Van Nhu LN Binh, Bull World Health Organ 1998 76 Suppl 1 51 58 9763723 (Pubitemid 128685314)
32. Pathways to malaria persistence in remote central Viet Nam: a mixed-method study of health care and the community. M Morrow QA Nguyen S Caruana BA Biggs NH Doan TT Nong, BMC Public Health 2009 9 85 10.1186/1471-2458-9-85 19309519
33. Social and environnemental determinants of malaria in space and time in Viet Nam. BH Manh ACA Clements QT Nguyen MH Nguyen XH Le SI Hay TH Tran HFL Wertheim RW Snow P Horby, Int J Parasitol 2010 41 109 116 20833173
34. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. RA Cooper MT Ferdig XZ Su LM Ursos J Mu T Nomura H Fujioka DA Fidock PD Roepe TE Wellems, Mol Pharmacol 2002 61 35 42 10.1124/mol.61.1.35 11752204 (Pubitemid 34049510)
35. Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. RA Cooper KD Lane B Deng J Mu JJ Patel TE Wellems X Su MT Ferdig, Mol Microbiol 2007 63 270 282 10.1111/j.1365-2958.2006. 05511.x 17163969 (Pubitemid 44968124)
36. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. AB Sidhu SG Valderramos DA Fidock, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034 (Pubitemid 41139856)
37. Illegal migration, a big problem in malaria control of Bu Dang district, Binh Phuoc province. TD Dao, J Malar Paras Dis Control 2001 1
38. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. P Singhasivanon, Southeast Asian J Trop Med Public Health 1999 30 suppl 4 1 101 i-iv 11444227
39. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine and quinine in Cambodia from 2001 to 2007. P Lim C Wongsrichanalai P Chim N Khim S Kim S Chy R Sem S Nhem P Yii S Duong DM Bouth B Genton H-P Beck JG Gobert WO Rogers J-Y Coppee T Fandeur O Mercereau-Puijalon P Ringwald J Le Bras F Ariey, Antimicrob Agents Chemother 2010 54 2135 2142 10.1128/AAC.01304-09 20194689
40. Malaria control in Vietnam: the Binh Thuan experience. N Van Nam PJ de Vries VT Le N Nagelkerke, Trop Med Int Health 10 357 365